Mode
Text Size
Log in / Sign up

Systematic review links shorter newborn transfer times to better survival in LMICs and HICsShorter travel times for newborns lead to better survival chances in many health settings

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that shorter newborn transfer times are associated with better survival, but evidence is observational and heterogeneous.

This is a systematic review with narrative synthesis and meta-analysis of 37 studies examining travel time or distance for small or sick newborns requiring transfer to health facilities. The scope included low- and middle-income countries (LMICs) and high-income countries (HICs). The authors synthesized associations between travel time and perinatal outcomes, including stillbirth, perinatal mortality, and neonatal mortality.

Key findings show positive associations between shorter travel times and survival. For interfacility journeys under 30 minutes, the odds of survival were greater than 3-fold higher (OR = 3.25, 95% CI = 1.90-5.57). For journeys from any location to hospitals at 2 hours, over 2-fold higher odds of survival were reported (OR = 2.06, 95% CI = 1.60-2.65). Similar associations were found at 1 hour (OR = 2.20, 95% CI = 1.46-3.33) and 30 minutes (OR = 1.92, 95% CI = 1.10-3.34).

The authors note substantial methodological heterogeneity and wide prediction intervals reflecting methodological and contextual diversity. Associations were weaker in HIC studies. Safety data were not reported.

Practice relevance suggests a travel time norm of 30 minutes or one hour may be preferable to the two-hour threshold currently used in LMICs, balanced with quality of care standards. The review does not establish causality, and pooled estimates are illustrative rather than definitive.

This large review looked at how far sick newborns must travel to reach a hospital. It combined data from thirty-seven different studies to see how travel time affects survival. The research included places with many resources as well as those with fewer resources.

Babies who traveled less than thirty minutes had a very high chance of surviving. Those who traveled up to two hours still had better odds than those on longer trips. The data suggests that shorter journeys are linked to healthier outcomes for newborns.

However, the results were not the same everywhere. Studies from wealthier countries showed weaker links between travel time and survival. The review notes that many different methods were used across the studies, which makes exact predictions difficult.

Experts say a standard of thirty minutes or one hour is better than two hours. This shorter time should be balanced with good quality care at the hospital. The findings help guide rules for moving sick babies safely to treatment.

What this means for you:
Shorter travel times for newborns are linked to better survival, but care quality also matters.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Evidence-based global guidance on safe travel time for small or sick newborns who require transfer to health facilities after birth is lacking. A two-hour threshold is frequently cited in low- and middle-income countries (LMICs), while 30 minutes is commonly used in high-income countries (HICs). Although these thresholds are widely referenced, their empirical basis and consistency across levels of newborn care and journey types have not been systematically examined. This study synthesises the evidence linking travel time and perinatal outcomes. METHODS: We conducted a systematic review with narrative synthesis and meta-analysis to assess the impact of travel time or distance (home-to-facility or interfacility) on stillbirth, perinatal mortality, and neonatal mortality. We searched Embase, MEDLINE, and Cochrane Central Register of Controlled Trials for published studies from 2014 to 2023. Given substantial methodological heterogeneity, we used narrative synthesis as the primary analytical approach and conducted random-effects meta-analyses where studies were sufficiently comparable (≥2 with similar definitions and outcome windows), pooling effect estimates for travel time thresholds of 30 minutes, 1 hour, or 2 hours and travel distances of 5, 10, and 15 km. We assessed bias using the Newcastle-Ottawa Scale for cohort and case-control studies. RESULTS: Of 8317 screened records, 166 were eligible for full-text review, with 37 studies meeting the inclusion criteria- All but two had low or moderate risk of bias. Most studies (n = 26) came from LMICs and documented higher perinatal survival with shorter journeys. Studies from HICs demonstrated lower out-of-hospital birth, lower morbidity, and lower mortality with shorter journeys though associations were weaker. Across the narrative synthesis, shorter travel times were consistently associated with better outcomes. Exploratory pooling suggested a greater than 3-fold higher odds of survival for interfacility journeys under 30 minutes (odds ratio (OR) = 3.25; 95% confidence interval (CI) = 1.90-5.57) and over 2-fold higher odds of survival for journeys from any location to hospitals at all thresholds (OR = 2.06; 95% CI = 1.60-2.65 for 2 hours; OR = 2.20; 95% CI = 1.46-3.33 for 1 hour; OR = 1.92; 95% CI = 1.10-3.34 for 30 minutes), though prediction intervals were wide, reflecting methodological and contextual diversity. CONCLUSIONS: We found that shorter journeys were associated with better perinatal outcomes, with the highest survival rates observed for journeys under 30 minutes to the hospital. Due to substantial contextual and methodological heterogeneity, pooled estimates should be interpreted as illustrative, rather than definitive. A travel time norm of 30 minutes or one hour is preferable to the two-hour threshold currently used in LMICs. To safeguard perinatal survival rates, any travel-time standard should be balanced with corresponding quality of care standards. REGISTRATION: PROSPERO: CRD42023460423.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.